SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-24-063234
Filing Date
2024-03-08
Accepted
2024-03-08 11:22:49
Documents
1
Group Members
LANTHEUS ALPHA THERAPY, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d749365dsc13da.htm SC 13D/A 78039
  Complete submission text file 0001193125-24-063234.txt   80184
Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 (509) 375-1202
Perspective Therapeutics, Inc. (Subject) CIK: 0000728387 (see all company filings)

IRS No.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-80930 | Film No.: 24732983
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filed by) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)